» Articles » PMID: 27529171

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease

Overview
Journal PLoS One
Date 2016 Aug 17
PMID 27529171
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In this study, we hypothesized that Parkinson patients with more non-motor symptoms have a different pattern of striatal dopamine depletion, particularly in areas other than the sensorimotor striatum, compared to those with fewer non-motor symptoms.

Methods: We conducted a prospective survey of the degree of non-motor symptoms (using the Korean version of the Non-Motor Symptoms Scale; K-NMSS) in 151 patients with early-stage Parkinson's disease who had undergone a dopamine transporter PET scan as an initial diagnostic procedure. We classified the patients into two groups; high non-motor patients (HNM-PD; K-NMSS score ≥ 41) and low non-motor patients (LNM-PD).

Results: Patients in the HNM-PD group (n = 71) were older, had longer symptom duration, exhibited more severe motor deficits, and had been prescribed higher levodopa-equivalent doses at follow-up than those in the LNM-PD group. However, dopamine transporter binding to the striatal sub-regions and inter-sub-regional binding ratios were comparable between the two groups. A general linear model showed that the HNM-PD group had significantly more severe motor deficits than the LNM-PD group after controlling for age, gender, symptom duration, and dopamine transporter binding to the sensorimotor striatum.

Conclusions: This study demonstrated that the pattern of striatal dopamine depletion does not contribute to early non-motor burden in Parkinson's disease. Our results suggest that LNM-PD patients may have a more benign course of motor symptom progression than HNM-PD patients.

Citing Articles

Cortical and subcortical morphological alterations in motor subtypes of Parkinson's disease.

Li J, Zhang Y, Huang Z, Jiang Y, Ren Z, Liu D NPJ Parkinsons Dis. 2022; 8(1):167.

PMID: 36470900 PMC: 9723125. DOI: 10.1038/s41531-022-00435-3.


Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.

Palermo G, Giannoni S, Bellini G, Siciliano G, Ceravolo R Int J Mol Sci. 2021; 22(20).

PMID: 34681899 PMC: 8538800. DOI: 10.3390/ijms222011234.


Emerging Concepts of Motor Reserve in Parkinson's Disease.

Chung S, Lee J, Lee P, Sohn Y J Mov Disord. 2020; 13(3):171-184.

PMID: 32854486 PMC: 7502292. DOI: 10.14802/jmd.20029.


Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.

Park S, Kwon K, Lee J, Im K, Sunwoo J, Lee K Neurol Sci. 2018; 40(2):311-317.

PMID: 30415448 DOI: 10.1007/s10072-018-3632-7.


The presence of depression in de novo Parkinson's disease reflects poor motor compensation.

Lee Y, Oh J, Chung S, Lee J, Chung S, Moon H PLoS One. 2018; 13(9):e0203303.

PMID: 30231066 PMC: 6145582. DOI: 10.1371/journal.pone.0203303.


References
1.
Chaudhuri K, Rojo J, Schapira A, Brooks D, Stocchi F, Odin P . A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS One. 2013; 8(2):e57221. PMC: 3584126. DOI: 10.1371/journal.pone.0057221. View

2.
Kingsbury A, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W . Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model. Mov Disord. 2010; 25(15):2508-15. DOI: 10.1002/mds.23305. View

3.
Lee D, Oh J, Ham J, Lee J, Lee I, Lee P . Is normosmic Parkinson disease a unique clinical phenotype?. Neurology. 2015; 85(15):1270-5. DOI: 10.1212/WNL.0000000000001999. View

4.
Gibb W, Lees A . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988; 51(6):745-52. PMC: 1033142. DOI: 10.1136/jnnp.51.6.745. View

5.
Oh M, Kim J, Kim J, Shin K, Park S, Kim H . Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med. 2012; 53(3):399-406. DOI: 10.2967/jnumed.111.095224. View